paperKB
coga / coga-kb
Help
Sign in

Chunk #34 — 3. Results — 3.2. Study 2: Insulin Action in the Nonhepatic Tissues

Source
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
Embedded
yes

Text

Indices of glucose utilization rates (R g′) in individual tissues are summarized in Table 4. In the basal state, R g′ of the red hindlimb muscle of the Tesaglitazar group was lower than in the Obese group, representing a normalization towards the values in the Lean group. White adipose tissue R g′, elevated in Obese versus Lean, was further elevated by tesaglitazar. In all insulin responsive tissues examined (i.e., not cerebellum) tesaglitazar markedly improved the ability of insulin to concentration dependently stimulate R g′ in the obese Zucker rat. An example showing the dependence of R g′ on plasma insulin is illustrated in Figure 3 for the RQ muscle. This treatment effect was so profound that it enabled quantitative estimation of insulin sensitivity (EC50 value for R g′ as defined in Section 2) in a number of tissues of the obese rat which was generally not possible in untreated animals due to a virtual absence of insulin effect. For the Tesaglitazar treated group the EC50 for white fat, diaphragm and RG were 0.7 nM (95% CI 0.4–1.0), 1.7 nM (1.1–2.7),